Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Cash from Financing Activities: 2012-2025

Historic Cash from Financing Activities for Prothena Corp Public (PRTA) over the last 13 years, with Sep 2025 value amounting to -$17,000.

  • Prothena Corp Public's Cash from Financing Activities fell 105.11% to -$17,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$198,000, marking a year-over-year decrease of 109.45%. This contributed to the annual value of $1.6 million for FY2024, which is 96.55% down from last year.
  • Prothena Corp Public's Cash from Financing Activities amounted to -$17,000 in Q3 2025, which was up 77.03% from -$74,000 recorded in Q2 2025.
  • Prothena Corp Public's Cash from Financing Activities' 5-year high stood at $220.8 million during Q4 2022, with a 5-year trough of -$74,000 in Q2 2025.
  • For the 3-year period, Prothena Corp Public's Cash from Financing Activities averaged around $4.2 million, with its median value being $444,000 (2024).
  • As far as peak fluctuations go, Prothena Corp Public's Cash from Financing Activities soared by 135,857.81% in 2021, and later slumped by 116.67% in 2025.
  • Quarterly analysis of 5 years shows Prothena Corp Public's Cash from Financing Activities stood at $1.8 million in 2021, then skyrocketed by 12,351.49% to $220.8 million in 2022, then tumbled by 99.78% to $483,000 in 2023, then crashed by 112.22% to -$59,000 in 2024, then tumbled by 105.11% to -$17,000 in 2025.
  • Its Cash from Financing Activities was -$17,000 in Q3 2025, compared to -$74,000 in Q2 2025 and -$48,000 in Q1 2025.